Escient Pharmaceuticals Is A Clinical Stage Biotechnology Company Dedicated To Developing Innovative Oral Therapeutics For Neurosensory Inflammatory Disordersas A Privately Held Entityescient Focuses On Drug Discovery And Developmentwith A Pipeline Of Oral Small Molecule Therapeutics Targeting Specific Receptors And Pathways Involved In These Conditions In November 2022Escient Secured $120 Million In Series C Financing To Support Its Clinical Programsthe Company Was Acquired By Incyte In May 2024Enhancing Incyteae S Portfolio In Neurosensory Inflammatory Therapeuticsescient S Strategic Focus Is On Identifying And Validating Novel Therapeutic Targetsaiming To Address Unmet Medical Needs In This Areathe Company Is Headquartered In San Diegocalifornia
